Schyler Webber, APRN
Psychiatric/Mental Health · Nashville, TNNPI 1184406142
Payments from drug & device makers
Across 87 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$240
- Alkermes, Inc.$219
- Otsuka America Pharmaceutical, Inc.$175
- AbbVie$157
- Axsome Therapeutics, Inc.$150
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$137
- plus $418 from 7 others
What the payments were for
- Food & beverage$1,495100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 9 | $240 |
| Alkermes, Inc. | 13 | $219 |
| Otsuka America Pharmaceutical, Inc. | 8 | $175 |
| AbbVie | 19 | $157 |
| Axsome Therapeutics, Inc. | 8 | $150 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $128 |
| Johnson & Johnson | 6 | $125 |
| E.r. Squibb & Sons, L.L.C. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Neurocrine Biosciences, Inc. | 2 | $31 |
| Tris Pharma Inc | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$1,495 in reported general payments places this provider in the 65th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 33 | $3,812 |
| Aripiprazole | 44 | $1,347 |
| Buspirone Hcl | 60 | $1,109 |
| Clozapine | 16 | $1,051 |
| Paliperidone ErPaliperidone | 11 | $847 |
| Duloxetine Hcl | 37 | $764 |
| Bupropion XlBupropion Hcl | 33 | $658 |
| Trazodone Hcl | 71 | $636 |
| Bupropion Hcl SrBupropion Hcl | 39 | $532 |
| Hydroxyzine Hcl | 23 | $455 |
| Mirtazapine | 15 | $442 |
| Olanzapine | 18 | $427 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $337 |
| Escitalopram Oxalate | 36 | $301 |
| Lithium Carbonate ErLithium Carbonate | 13 | $286 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Nashville
- Kristian DambrinoNashville$449K
- Lauren HansenNashville$263K
- Aaron JonesNashville$20K
- Kathleen McCoyNashville$12K
- Preeti SrivastavaNashville$11K
- Kersten WoodleeNashville$10K
- Ariel NewtonNashville$10K
- Robert McKeownNashville$10K
- Debra YorkNashville$9K
- Laura MelaroBolivar$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.